Stu G. Fillman
Kensington, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.
Journal: Journal of neuroinflammation
Published: May 01, 2017
Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.
Journal: Molecular psychiatry
Published: August 24, 2014
Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation.
Journal: The Australian and New Zealand journal of psychiatry
Published: April 19, 2014
Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers.
Journal: Schizophrenia research
Published: November 21, 2013
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.
Journal: Translational psychiatry
Published: November 07, 2013
High white matter neuron density with elevated cortical cytokine expression in schizophrenia.
Journal: Biological psychiatry
Published: May 30, 2013
Rethinking schizophrenia in the context of normal neurodevelopment.
Journal: Frontiers in cellular neuroscience
Published: February 13, 2013
Markers of inflammation in the prefrontal cortex of individuals with schizophrenia.
Journal: Molecular psychiatry
Published: January 25, 2013
Increases in [3H]muscimol and [3H]flumazenil binding in the dorsolateral prefrontal cortex in schizophrenia are linked to α4 and γ2S mRNA levels respectively.
Journal: PloS one
Published: August 23, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026